TD Cowen Sticks to Their Hold Rating for SAGE Therapeutics (SAGE)
TD Cowen analyst Ritu Baral maintained a Hold rating on SAGE Therapeutics (SAGE – Research Report) today and set a price target of $8.50. The company's shares closed today at $9.07.
Confident Investing Starts Here:
Baral covers the Healthcare sector, focusing on stocks such as Sarepta Therapeutics, Alnylam Pharma, and Neurogene. According to TipRanks, Baral has an average return of 7.3% and a 46.40% success rate on recommended stocks.
SAGE Therapeutics has an analyst consensus of Hold, with a price target consensus of $8.75, representing a -3.53% downside. In a report released today, Wedbush also maintained a Hold rating on the stock with a $8.50 price target.
Based on SAGE Therapeutics' latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $14.06 million and a GAAP net loss of $62.21 million. In comparison, last year the company earned a revenue of $7.9 million and had a GAAP net loss of $108.48 million
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
40 minutes ago
- Yahoo
Fiserv Is Launching a Bank Stablecoin. Should You Buy FI Stock Here?
Fiserv (FI) shares are inching up on Monday after the financial technology company announced plans of launching its own stablecoin (FIUSD) by the end of 2025. In its press release, the financial technology giant said FIUSD will be integrated into its 'existing banking and payments infrastructure' over the next six months. The Next Trillion-Dollar Boom? 3 Stocks to Buy with 300 Million Humanoid Robots on the Horizon. Is Tesla a Buy or Sell as TSLA Stock Zooms on Austin Robotaxi Launch? These 3 Stocks Have Been Hot in 2025. Should You Sell Them Now Before It's Too Late? Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market analysis you won't find anywhere else. Despite today's gain, Fiserv stock is down more than 25% versus its year-to-date high. On Monday, the NYSE-listed firm said it has partnered with Circle (CRCL), Paxos, and even Solana to roll out a new digital asset platform powered by FIUSD. Additionally, Fiserv has teamed up with PayPal (PYPL) to make its stablecoin interoperable with PYUSD and make it incrementally easier for 'consumers and businesses to move funds domestically and internationally.' The development is largely positive for FI shares as it positions the multinational to capitalize on continued momentum in the stablecoin market that Seaport Research believes has already hit $260 billion in market cap. Following the Senate's approval of the GENIUS Act last week, the investment firm expects the stablecoin market to scale rapidly and hit a $500 billion valuation by the end of next year and up to $2.0 trillion longer term. TD Cowen dubbed the FIUSD announcement a 'positive indicator' as it reiterated its 'Buy' rating on Fiserv stock on Monday. In its research note, the investment firm said FI's plans of launching a stablecoin signal its 'ability to innovate rapidly.' Additionally, the fintech is primed to 'leverage central positioning between financial institutions and merchants to bridge traditional and emerging payment systems,' it added. TD Cowen analysts currently have a $233 price objective on Fiserv shares that indicates potential upside of another 40%. Other Wall Street analysts also see FI shares as potentially undervalued and recommend loading up on them at current levels. According to Barchart, the consensus rating on Fiserv stock currently sits at 'Strong Buy' with the mean target of about $220 indicating potential upside of more than 30% from here. On the date of publication, Wajeeh Khan did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on
Yahoo
4 hours ago
- Yahoo
TD Cowen Cuts Victoria's Secret Target to $22, Says Core Business Still Lags
TD Cowen lowered its price target on Victoria's Secret (NYSE:VSCO) from $25 to $22 a few days earlier, holding its Neutral stance as the lingerie retailer continues to struggle with margin pressure and weak core category performance. The stock is currently trading near $19, down more than 52% year-to-date, with a market cap of $1.58 billion. The downgrade follows a rough first quarter, where gross margins came in below expectations. While the company benefited from lower SG&A, thanks to a shift in marketing spend from Q1 into Q2, Cowen pointed to the growing reliance on 'gift with purchase' promotions, which undercut pricing and dragged on margins. Unit sales during the semiannual sale also saw double-digit declines, raising further questions about consumer demand. Still, there were a few positives. The PINK apparel line, beauty segment, and VSX activewear all delivered solid results. But analysts made it clear that the company's core intimates business, the foundation of the brand, 'needs more work.' TD Cowen also warned that the second half of the year could bring difficult comps, particularly given the major lift Victoria's Secret (NYSE:VSCO) saw from its fashion show last year. The updated $22 price target is based on a 9x multiple of projected 2027 earnings. It suggests marginal near-term upside without a turnaround in fundamentals. The company remains profitable, with $586 million in EBITDA over the past 12 months, but momentum is shaky, and the stock continues to show that uncertainty. Last month we talked about . While we acknowledge the potential of VSCO as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Sign in to access your portfolio
Yahoo
9 hours ago
- Yahoo
The Top 5 Analyst Questions From Teradyne's Q1 Earnings Call
Teradyne's first quarter results landed in line with Wall Street's revenue expectations, but market reaction was negative following the earnings release. Management attributed the quarter's year-over-year sales growth to demand in its semiconductor test (Semi Test) business, particularly for mobile system-on-chip (SoC) testers, as well as increased activity in AI accelerator testing. CEO Greg Smith clarified that mobile demand was driven by supply chain transitions rather than an end-market recovery, and noted that the company's memory business secured a new high bandwidth memory (HBM4) test win. While product mix benefited gross margins, management pointed to ongoing challenges in the robotics segment and a generally cautious near-term outlook due to persistent uncertainty around customer capital spending. Is now the time to buy TER? Find out in our full research report (it's free). Revenue: $685.7 million vs analyst estimates of $683.9 million (14.3% year-on-year growth, in line) Adjusted EPS: $0.75 vs analyst estimates of $0.62 (21.7% beat) Adjusted EBITDA: $166.3 million vs analyst estimates of $144.9 million (24.3% margin, 14.8% beat) Revenue Guidance for Q2 CY2025 is $645 million at the midpoint, roughly in line with what analysts were expecting Adjusted EPS guidance for Q2 CY2025 is $0.53 at the midpoint, below analyst estimates of $0.53 Operating Margin: 17.6%, up from 13% in the same quarter last year Inventory Days Outstanding: 116, up from 88 in the previous quarter Market Capitalization: $13.84 billion While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention. Krish Sankar (TD Cowen) asked how tariffs are affecting customer order patterns. CEO Greg Smith responded that pushouts are mainly from automotive and industrial customers, while mobile demand remains stable for now. C.J. Muse (Cantor Fitzgerald) probed for full-year gross margin expectations. CFO Sanjay Mehta explained that margin variability will depend on product mix and top-line trends, and management is not providing full-year guidance due to uncertainty. Timothy Arcuri (UBS) inquired about the timing and impact of the record robotics order. Smith clarified that shipments are spread across Q1 and Q2, with no immediate extension into the second half. Priyanka Thapa (JPMorgan) asked whether tariffs have shifted customer preferences to non-U.S. suppliers. Smith replied that tariffs have not led to a loss of competitive positioning or caused customers to switch vendors. Shane Brett (Morgan Stanley) questioned what would drive renewed demand in the NAND memory testing market. Smith pointed to mobile phone volume growth and evolving AI-enabled device requirements as key factors. Looking ahead, the StockStory team will be watching (1) how global trade policy developments and tariffs influence customer spending and order timing, (2) whether Semi Test and memory growth can offset continued softness in robotics and product test, and (3) progress on new product initiatives such as silicon photonics testing and enterprise robotics automation. Shifts in customer capital spending and execution on cost controls will also be critical indicators. Teradyne currently trades at $86.92, up from $76.83 just before the earnings. Is the company at an inflection point that warrants a buy or sell? Find out in our full research report (it's free). The market surged in 2024 and reached record highs after Donald Trump's presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025. While the crowd speculates what might happen next, we're homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver's seat and build a durable portfolio by checking out our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
